Nongenomic estrogen action in human lung myofibroblasts

被引:27
作者
Flores-Delgado, G
Bringas, P
Buckley, S
Anderson, KD
Warburton, D
机构
[1] Univ So Calif, Childrens Hosp Los Angeles, Res Inst, Dev Biol Program, Los Angeles, CA 90027 USA
[2] Univ So Calif, Childrens Hosp Los Angeles, Res Inst, Dept Pediat Surg, Los Angeles, CA 90027 USA
[3] Univ So Calif, Keck Sch Med & Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90027 USA
关键词
nongenomic estrogen action; smooth muscle-like cells; Raf1; MAP kinases;
D O I
10.1006/bbrc.2001.4827
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recent studies have suggested that the antiproliferative effects of E2 may be mediated through a nongenomic action, Herein, we asked whether nongenomic estrogen action regulates phosphorylation of Raf1 and ERK1/2 mitogen-activated protein (MAP) kinase in lung myofibroblasts. We demonstrated that lung myofibroblasts, incubated in the presence of E2, showed a rapid phosphorylation on serine-259 of Raf1 and tyrosine-204 of ERK1/2 MAP kinase at 15 min, by approximately 3- and 5-fold, respectively. This phosphorylation was followed by dephosphorylation between 30 and 60 min. Western blot analysis showed that E2 regulates tyrosine phosphorylation of four main cytoplasmic proteins in lung myofibroblasts, of 42, 44, 70 and 100 kDa, Furthermore, our results indicated that E2 inhibits cell proliferation (BrdU index) in lung myofibroblasts by approximately 30% (P < 0.01). These data provide evidence that nongenomic action of E2, regulates both serine and tyrosine phosphorylation of cytoplasmic proteins in lung myofibroblasts, including Raf1 and ERK1/2 MAP kinase, which may regulate proliferation in lung myofibroblasts. (C) 2001 Academic Press.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 29 条
[1]
Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus [J].
Brandenberger, AW ;
Tee, MK ;
Lee, JY ;
Chao, V ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) :3509-3512
[2]
Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation [J].
Brondello, JM ;
Pouysségur, J ;
McKenzie, FR .
SCIENCE, 1999, 286 (5449) :2514-2517
[3]
Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae [J].
Chambliss, KL ;
Yuhanna, IS ;
Mineo, C ;
Liu, PS ;
German, Z ;
Sherman, TS ;
Mendelsohn, ME ;
Anderson, RGW ;
Shaul, PW .
CIRCULATION RESEARCH, 2000, 87 (11) :E44-E52
[4]
Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms [J].
Dubey, RK ;
Jackson, EK .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (03) :F365-F388
[5]
Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity [J].
Dubey, RK ;
Jackson, EK ;
Gillespie, DG ;
Zacharia, LC ;
Imthurn, B ;
Keller, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :964-972
[6]
Rapid activation of MAP kinase by estrogen in the bone cell line [J].
Endoh, H ;
Sasaki, H ;
Maruyama, K ;
Takeyama, K ;
Waga, I ;
Shimizu, T ;
Kato, S ;
Kawashima, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (01) :99-102
[7]
Falkenstein E, 2000, PHARMACOL REV, V52, P513
[8]
Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells [J].
Hayashi, K ;
Takahashi, M ;
Kimura, K ;
Nishida, W ;
Saga, H ;
Sobue, K .
JOURNAL OF CELL BIOLOGY, 1999, 145 (04) :727-740
[9]
Postmenopausal hormone replacement therapy and the vascular wall:: Mechanisms of 17 β-estradiol's effects on vascular biology [J].
Joswig, M ;
Hach-Wunderle, V ;
Ziegler, R ;
Nawroth, PP .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1999, 107 (08) :477-487
[10]
Kaiser U, 1996, INT J CANCER, V67, P357, DOI 10.1002/(SICI)1097-0215(19960729)67:3<357::AID-IJC9>3.0.CO